Back to results
US 12,186,282 B2Granted
Treatment of 22Q11.2 deletion syndrome with cannabidiol
AssigneeHarmony Biosciences Management, Inc.
InventorsTerri Sebree, Donna Gutterman
Life of this patent
Estimating the term…
Abstract
The present technology relates to methods of treating one or more behavioral symptoms (for example, anxiety) of 22q 11.2 deletion syndrome in a subject by administering, e.g., transdermally, an effective amount of cannabidiol (CBD) to the subject wherein one or more behavioral symptoms of 22q 11.2 deletion syndrome are treated in the subject.
Claims20
A method of treating one or more behavioral and/or psychiatric symptoms of 22q11.2 deletion syndrome in a subject, the method comprising:
- administering an effective amount of cannabidiol (CBD) to the subject wherein one or more behavioral and/or psychiatric symptoms of 22q11.2 deletion syndrome are treated in the subject.
Dependencies are inferred from the claim text.